Welcome to our dedicated page for Enhabit news (Ticker: EHAB), a resource for investors and traders seeking the latest updates and insights on Enhabit stock.
Enhabit Inc (EHAB) provides essential home health and hospice care services across the United States, delivering Medicare-certified skilled nursing and compassionate end-of-life support directly to patients' homes. This news hub offers investors and industry professionals a centralized source for tracking the company's operational developments and market position.
Access timely updates on earnings reports, strategic partnerships, regulatory compliance milestones, and leadership announcements. Our curated collection includes press releases about service expansions, quality care initiatives, and technology integrations that maintain Enhabit's competitive edge in home-based healthcare.
Key updates cover both segments of Enhabit's operations: home health services focused on rehabilitation and chronic care management, plus hospice services emphasizing patient comfort and family support. Stay informed about operational metrics, industry recognition, and evolving care models without promotional bias.
Bookmark this page for streamlined access to verified information about Enhabit's clinical advancements and financial performance. Check back for objective reporting on how the company navigates healthcare regulations and meets growing demand for personalized home care solutions.
Enhabit Inc. (NYSE: EHAB), a national home health and hospice provider, has scheduled its first quarter 2025 earnings release and conference call. The company will announce Q1 2025 results on May 7, 2025, followed by a conference call and webcast on May 8, 2025 at 10 a.m. EDT.
Enhabit operates across 34 states with 255 home health locations and 115 hospice locations. The company specializes in home-based patient care, utilizing advanced technology and clinical teams to deliver healthcare services.
Enhabit Inc. (NYSE: EHAB), a leading home health and hospice provider, has achieved Level 2 recognition as an Age-Friendly Health System – Committed to Care Excellence from the Institute for Healthcare Improvement (IHI). The recognition highlights Enhabit's implementation of the 4Ms framework: What Matters, Medication, Mentation, and Mobility.
The initiative, led by The John A. Hartford Foundation and IHI in partnership with the American Hospital Association and the Catholic Health Association, focuses on delivering personalized, evidence-based care to older adults. Enhabit's nationwide operations span 255 home health locations and 115 hospice locations across 34 states, implementing a comprehensive care model that emphasizes patient-centered approaches and strengthens relationships between patients and care teams.
Enhabit (NYSE: EHAB) reported its Q4 2024 financial results, showing mixed performance across segments. The company posted net service revenue of $258.2 million but recorded a net loss of $46.0 million, with loss per share of $0.92 and adjusted earnings per share of $0.04.
Key highlights include a 10.7% increase in home health non-Medicare admissions and 48% of non-Medicare visits now in payer innovation contracts at improved rates. The hospice segment showed strong growth with an 8.6% year-over-year increase in average daily census and 6.5% growth in admissions. Hospice net service revenue and Adjusted EBITDA both increased by approximately 13% year-over-year.
The company reduced bank debt by $10 million in Q4, totaling $40 million in debt reduction for 2024. Operational efficiency improved with home office G&A expenses decreasing by 12%. The company expanded its footprint with three new hospice locations in Q4, bringing the 2024 total to one home health and five hospice de novo locations.
Enhabit Home Health & Hospice (NYSE: EHAB) has announced plans to nominate Stephan Rodgers to its Board of Directors at the company's 2025 annual stockholders meeting. Rodgers brings 25 years of executive-level experience, including serving as CEO of AccentCare for over a decade and holding senior positions at UnitedHealth Group.
Rodgers' extensive background includes managing healthcare benefits for GE and service in the U.S. Army Special Forces. Due to non-compete obligations from his AccentCare role, Rodgers will join the board after June 30, 2025, if elected.
Enhabit currently operates 256 home health locations and 112 hospice locations across 34 states, focusing on expanding patient care possibilities in the home setting through advanced technology and clinical teams.
Enhabit (NYSE: EHAB), a national home health and hospice provider, has scheduled its Q4 2024 earnings release for March 5, 2025, followed by a conference call on March 6, 2025, at 10 a.m. EDT. The company operates across 34 states with 256 home health locations and 112 hospice locations.
Investors and interested parties can join the conference call using toll-free number 888-660-6150 or international number 929-203-0843 with Conference ID 5248158. A webcast will be available through the company's investor website.
Enhabit (NYSE: EHAB), a leading national home health and hospice provider, has received the Great Place To Work Certification™ for 2025. The certification is based on current employee feedback, with 83% of employees rating it as a great workplace - 26 points above the U.S. company average.
The company operates across 34 states with 256 home health locations and 112 hospice locations, employing over 10,000 staff. Enhabit offers competitive benefits, flexible schedules, professional development, and advanced technology to support patient care. As one of the largest Medicare-certified providers in the nation, the company focuses on expanding possibilities for home-based patient care.
Encompass Health and Enhabit have won a significant lawsuit in the Delaware Court of Chancery against former senior officers April Anthony, Luke James, and Chris Walker for breaches of fiduciary duty. The Court also ruled against private equity firms Vistria Group and Nautic Partners for aiding these breaches.
The Court found that the defendants misappropriated acquisition opportunities, used confidential information, and recruited key employees while still employed at Encompass Health. As compensation, the Court awarded 43% of VitalCaring Group's profits to Encompass Health and Enhabit, plus $1.62 million in mitigation damages and attorneys' fees.
The defendants were found to have deliberately concealed their actions through falsifying records, deleting evidence, and manipulating communications. The Court's decision sends a clear message about the consequences of breaching fiduciary duties and self-dealing by corporate officers.
Encompass Health and Enhabit have won a significant legal victory in the Delaware Court of Chancery against former senior officers April Anthony, Luke James, and Chris Walker for breaches of fiduciary duty. The court found that while employed at Encompass Health, these officers misappropriated acquisition opportunities, used confidential information, and recruited employees for a competing venture.
The Court awarded damages against private equity firms Vistria Group and Nautic Partners for aiding these breaches. The remedy includes a constructive trust entitling Encompass Health and Enhabit to 43% of VitalCaring Group's profits and future exit proceeds, approximately $1.62 million in mitigation damages, and attorneys' fees due to defendants' bad faith conduct including evidence tampering.
Enhabit (NYSE: EHAB), a leading home health and hospice provider, announced its participation in the BofA Securities 2024 Home Care Conference. President and CEO Barb Jacobsmeyer, incoming CFO Ryan Solomon, and SVP of Strategic Finance & Treasurer Jobie Williams will participate in a fireside chat on Tuesday, Dec. 10, at 9:00 a.m. EST. The event will be webcast live and available for replay on the company's investor website. Enhabit operates 256 home health locations and 112 hospice locations across 34 states, leveraging advanced technology for patient care delivery.
Enhabit Home Health & Hospice (NYSE: EHAB) has appointed Ryan Solomon as its new Chief Financial Officer, effective Dec. 9, 2024. Solomon brings over 20 years of corporate strategy and finance experience, including eight years as CFO in home health and hospice. He previously served as CFO at AccentCare and Aspirion, where he managed financial planning, accounting, tax, treasury, revenue cycle, and corporate development. Solomon will replace Crissy Carlisle, the current CFO, as part of a previously announced transition. His experience includes building finance teams, systems integration, mergers and acquisitions, and operational business planning.
